NDC product
vecuronium bromide
NDC 47335-931 · Sun Pharmaceutical Industries, Inc.
Key facts
| Product NDC | 47335-931 |
|---|---|
| Proprietary name | vecuronium bromide |
| Nonproprietary name | vecuronium bromide |
| Substances | VECURONIUM BROMIDE |
| Dosage form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA079001 |
| Pharmacologic classes | Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC] |
| Marketing start | Dec 15, 2014 |
| Marketing end | Mar 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory